Novartis Vaccines and Diagnostics, Inc.
Date: November 2011
Purpose: to manufacture clinical lots of HIV proteins for efficacy evaluation of poxvirus/protein prime-boost regimes in Southern Africa
Amount: $14,756,274
Term: 2 years and 9 months
Grantee Location: Cambridge, Massachusetts